Dapsone Induced Methemoglobinemia and Hemolysis in a G6PD Deficient Girl, Possibly Aggravated by Aggressive Methylene Blue Therapy. (2013)

Peer-Reviewed Study · Ghatak T, Poddar B, Baronia AK · September 2013

Ghatak T et al., 2013-09: Indian 2013 case report of a G6PD-deficient girl whose dapsone-induced methemoglobinemia and haemolysis were possibly aggravated by aggressive methylene blue therapy.

Dapsone Induced Methemoglobinemia and Hemolysis in a G6PD Deficient Girl, Possibly Aggravated by Aggressive Methylene Blue Therapy.

410

Ghatak T et al., 2013-09: Indian 2013 case report of a G6PD-deficient girl whose dapsone-induced methemoglobinemia and haemolysis were possibly aggravated by aggressive methylene blue therapy. C9 India (Indian J Dermatol 58(5):410). Study type: single case report, N=1. Methylene blue given intravenously, 'aggressive' dosing per the title; exact dose not in record. Funder/conflicts: none declared. Bearing CONTRADICTS the safety reading: in G6PD deficiency methylene blue can worsen haemolysis – the reason every label lists G6PD deficiency as a contraindication. Study type: case report.